Mrs Rose Hamershock

Brigham and Women's Hospital, Boston (United States of America)

Follow

Contributor content

Comparison of analysis methodologies for net outcome with edoxaban vs warfarin in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

Presentation

Comparison of analysis methodologies for net outcome with edoxaban vs warfarin in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

ESC 365 is supported by

novartis

Explore sponsored resources